Clinical Trials Directory

Trials / Terminated

TerminatedNCT00178542

Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle

Changes in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle

Status
Terminated
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to describe characteristics and trends for thrombin generation (TG) and thromboelastography (TEG) at 4 time points during the menstrual cycle.

Detailed description

We propose that TG and TEG will be more sensitive than traditional coagulation assays to detect physiologic variation in hemostasis, fibrinolysis, and platelet activation throughout the menstrual cycle. We expect that TG and TEG will better discriminate patients with vWD than traditional coagulation studies during the menstrual cycle. In this study we plan to measure TG and TEG in healthy women and women with von Willebrand's disorder during four phases of the menstrual cycle. We will compare specific measurements of endogenous thrombin generation potential from the TG and fibrinolysis and platelet activation from the TEG with standard measures of coagulation, fibrinolysis, and platelet activation markers during the menstrual cycle.

Conditions

Timeline

Start date
2005-09-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2005-09-15
Last updated
2013-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00178542. Inclusion in this directory is not an endorsement.